Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Peters

Showing results (1161-1170 of 1,183) with videos related to

Pageof 119
Sort By:
Frontiers in Immunology|July 11, 2025
Nanolipoprotein particle (NLP) vaccine confers protection against <i>Yersinia pestis</i> aerosol challenge in a BALB/c mouse modelSergei S Biryukov, Amy Rasley, Michael L Davies, et al.
Iscience|September 14, 2022
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infectionA H Ayesha Lavell, Jonne J Sikkens, Arthur W D Edridge, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected PatientsVincent Lo Re, Craig W Newcomb, Dena M Carbonari, et al.
JAMA Network Open|July 28, 2021
Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care WorkersJonne J Sikkens, David T P Buis, Edgar J G Peters, et al.
Diabetes Care|September 6, 2024
Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot UlcerationAleksandra Staniszewska, Frances Game, Jane Nixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Hepatology (Baltimore, Md.)|March 29, 2021
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North AmericaH Nina Kim, Craig W Newcomb, Dean M Carbonari, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
Contemporary Clinical Trials|June 2, 2025
Rifampicin combination therapy versus targeted antimicrobial monotherapy in the oral antimicrobial treatment phase of staphylococcal prosthetic joint infection (RiCOTTA-trial): protocol for a randomized, controlled, open-label, non-inferiority trialJaap L J Hanssen, Esther Y van Hulten, Pieter K Bos, et al.
JAMA Network Open|February 17, 2021
Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015Jing Sun, Keri N Althoff, Yuezhou Jing, et al.
Pageof 119

Showing results (1161-1170 of 1,183) with videos related to

Sort By:
Pageof 119
Frontiers in Immunology|July 11, 2025
Nanolipoprotein particle (NLP) vaccine confers protection against <i>Yersinia pestis</i> aerosol challenge in a BALB/c mouse modelSergei S Biryukov, Amy Rasley, Michael L Davies, et al.
Iscience|September 14, 2022
Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infectionA H Ayesha Lavell, Jonne J Sikkens, Arthur W D Edridge, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 21, 2019
Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected PatientsVincent Lo Re, Craig W Newcomb, Dena M Carbonari, et al.
JAMA Network Open|July 28, 2021
Serologic Surveillance and Phylogenetic Analysis of SARS-CoV-2 Infection Among Hospital Health Care WorkersJonne J Sikkens, David T P Buis, Edgar J G Peters, et al.
Diabetes Care|September 6, 2024
Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot UlcerationAleksandra Staniszewska, Frances Game, Jane Nixon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy ErasMarina B Klein, Keri N Althoff, Yuezhou Jing, et al.
Hepatology (Baltimore, Md.)|March 29, 2021
Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North AmericaH Nina Kim, Craig W Newcomb, Dean M Carbonari, et al.
European Heart Journal|May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participantsJackie Bosch, Eva M Lonn, Hyejung Jung, et al.
Contemporary Clinical Trials|June 2, 2025
Rifampicin combination therapy versus targeted antimicrobial monotherapy in the oral antimicrobial treatment phase of staphylococcal prosthetic joint infection (RiCOTTA-trial): protocol for a randomized, controlled, open-label, non-inferiority trialJaap L J Hanssen, Esther Y van Hulten, Pieter K Bos, et al.
JAMA Network Open|February 17, 2021
Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015Jing Sun, Keri N Althoff, Yuezhou Jing, et al.
Pageof 119